Simplex Trading’s Cidara Therapeutics CDTX Stock Holding History

Simplex Trading’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,100	Closed	-$9.08M	–	9143
2025 Q4	$9.08M	Buy	41,100 +13,500	+49%	+$2.18M	0.01%	910
2025 Q3	$2.64M	Sell	27,600 -79,800	-74%	-$5.09M	﹤0.01%	2041
2025 Q2	$5.23M	Buy	+107,400	New	+$2.58M	﹤0.01%	1304
2023 Q4	–	Sell	-100	Closed	-$1K	–	8860
2023 Q3	$1K	Buy	+100	New	+$1.96K	﹤0.01%	8264
2020 Q4	–	Sell	-2	Closed	-$13K	–	8380
2020 Q3	$13K	Buy	+2	New	+$141	﹤0.01%	6638
2018 Q2	–	Sell	-3	Closed	-$11K	–	7386
2018 Q1	$11K	Buy	+3	New	+$410	﹤0.01%	3939

Simplex Trading's CDTX Position: Q1 2026 in Review

Simplex Trading sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 5,230 shares — an estimated $1.16M sold.

Simplex Trading first reported a position in CDTX in Q1 2018 and held it in 11 quarters. The position peaked at $3.31M in Q2 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Simplex Trading reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Simplex Trading sold 5,230 Cidara Therapeutics shares in Q1 2026, an estimated $1.16M.
Simplex Trading first reported a position in Cidara Therapeutics in Q1 2018 and held it in 11 quarters.
Simplex Trading's Cidara Therapeutics position peaked at $3.31M in Q2 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.